Epitalon vs Vesugen
How Epitalon and Vesugen compare — what each is, how strong the human evidence is for each, doses reported in research, the key risks, and 2026 US legal status. No universal winner.
Epitalon and Vesugen come up together when people are weighing similar options. Here's the honest side-by-side: what each is, how strong the human evidence is for each, the doses reported in research, the risks, and where each stands with the FDA as of 2026. There's no universal winner — scroll to the by-goal picks for which one fits which goal.
Epitalon vs Vesugen, point by point
Every dimension side by side — the honest differences, not a scoreboard.
| Dimension | Epitalon | Vesugen |
|---|---|---|
| What it is | Synthetic pineal tetrapeptide (a 4-amino-acid peptide, Ala-Glu-Asp-Gly, modeled on the pineal-gland extract epithalamin) | Synthetic tripeptide bioregulator (a three-amino-acid peptide associated with vascular tissue research) |
| Class / category | Longevity / mitochondrial | Longevity / mitochondrial |
| Evidence tier | Animal-only · Unclear · none in humans | In-vitro · Unclear |
| Studied / approved for | Anti-aging / lifespan extension; Telomere maintenance; Sleep & circadian regulation | Vascular-cell aging; Vasculogenic erectile dysfunction; Biological-aging markers |
| US regulatory status (2026) | research use only (as of Jul 2026) | research use only (as of Jul 2026) |
| Doses reported in research | No established study doses | No established study doses |
| Registered trials (ClinicalTrials.gov) | 0 | No data |
| Banned in sport (WADA) | Yes — on the WADA prohibited list | Yes — on the WADA prohibited list |
| Key risks | Epitalon's honest safety answer is "we don't really know in humans." No human safety trial of the synthetic peptide has been published, and long-term human data does not exist. Animal studies reported few obvious toxic effects at the small doses used, which is reassuring but not the same as human safety. The bigger real-world risk is the product itself — research-chemical vials vary in purity and sterility. | Vesugen has no adequate controlled human safety program and no long-term human trial. Small reports do not establish adverse-event rates, contraindications, interactions, dose accuracy, or product sterility. One human report also noted pro-oxidant activity and a decrease in circulating CD34-positive cells, findings whose clinical meaning remains unclear. |
- Evidence tier: A tier reflects how human the evidence is, not a promise the compound works.
Epitalon vs Vesugen: the two molecules
The 2D chemical structures, straight from PubChem — a quick way to see how similar (or not) the two actually are.
Which one fits which goal?
There's no universal winner here — the honest answer depends on what you're after. These picks are framed by goal, and each says why.
If you want the option with more human evidence behind it
Leans toward Epitalon
Epitalon's evidence sits at animal-only, a more human tier than Vesugen's in-vitro. That reflects how the data was gathered, not a guarantee it works.
References
- 1.Khavinson et al. 2003 — epitalon induces telomerase & telomere elongation in human cells (PubMed)
- 2.Al-dulaimi et al. 2025 — epitalon increases telomere length in human cell lines (PubMed)
- 3.Anisimov et al. 2003 — epitalon, lifespan & tumor incidence in SHR mice (PubMed)
- 4.Khavinson & Morozov 2003 — pineal & thymus peptides (epithalamin) and human life (PubMed)
- 5.Araj et al. 2025 — overview review of epitalon (PubMed)
- 6.Epitalon — registered clinical studies (ClinicalTrials.gov)